Mingfeng Xia

机构：Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-5650-0165

发表论文 146 篇 · 总被引 4287 次 · h-index 35

代表论文

• A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease (2024 · Journal of Hepatology · 被引 41)
• Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes (2025 · Nature Medicine · 被引 34)
• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Intermittent compared with continuous calorie restriction for treatment of metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial (2024 · American Journal of Clinical Nutrition · 被引 26)
• Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals (2024 · Current Obesity Reports · 被引 21)
• IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFR-STAT3 pathway (2024 · Molecular Metabolism · 被引 13)